Protean manifestations of vitamin D deficiency, part 1: The epidemic of deficiency

Southern Medical Journal

Volumn 104, Issue 5, 2011, Pages 331-334

  Bell, David S H ^a,b  

^a Southside Endocrinology   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune disease; cancer; cardiovascular disease; diabetes; vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; VITAMIN D;

ADIPOSE TISSUE; BIRTH WEIGHT; DISEASE ASSOCIATION; HUMAN; LIFESTYLE MODIFICATION; OBESITY; OSTEOMALACIA; PREECLAMPSIA; PREMATURE LABOR; PREVALENCE; REVIEW; RICKETS; RISK FACTOR; SKIN PIGMENTATION; SUN EXPOSURE; VITAMIN D DEFICIENCY;

AGED, 80 AND OVER; FEMALE; HUMANS; LIFE STYLE; OSTEOMALACIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RICKETS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79955639593     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318213d0f9     Document Type: Review

References (51)

1. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-1956.
2. Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010;55:1283-1288.
3. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94: 3849-3856.
4. Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205:255-260.
5. Ginde AA, Scragg R, Schwartz RS, et al. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and allcause mortality in older U.S. adults. J Am Geriatr Soc 2009;57: 1595-1603.
6. Ngo DT, Sverdlov AL, McNeil JJ, et al. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 2010;123:335-341.
7. Hjelmesaeth J, Hofs D, Aasheim ET, et al. Parathyroid hormone, but not vitamin D, is associated with metabolic syndrome in morbidly obese women and men: A cross-sectional study. Cardiovasc Diabetol 2009;8:7.
8. Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet B and blood pressure. Lancet 1998;352:709-710. (Pubitemid 28398716)
9. Sugden JA, Davies JI,Witham MD, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320-325. (Pubitemid 351322698)
10. Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: A randomised controlled trial. Diabetologia 2010;53: 2112-2119.
11. Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009;63:458-464.
12. Kazlauskaite R, Powell LH, Mandupakala C, et al. Vitamin D is associated with atheroprotective high-density lipoprotein profile in post-menopausal women. J Clin Lipidol 2010;4:113-119.
13. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-698.
14. Walker MD, Fleischer J, Rundek T, et al. Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94: 3849-3856.
15. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
16. Blair TM. Paper presented at the American College of Cardiology meeting; Atlanta, GA; March 16, 2010.
17. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiograph. J Clin Endocrinol Metab 2008;93:3927-3935.
18. Liu L. Serum 25-hydroxy vitamin D concentration: Heart failure mortality and premature death from all causes in US adults: An eight year follow-up study. Heart Failure Society of America. 2010. Abstract 018.
19. Boxer RS, Dauser DA,Walsh SJ, et al. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008;56:454-461. (Pubitemid 351327953)
20. Pilz S, Tomaschitz A, Ritz E, et alMedscape. Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol 2009;6:621-630.
21. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-238. (Pubitemid 34787360)
22. Nemerovski CW, Dorsch MP, Simpson RU, et al. Vitamin D and cardiovascular disease. Pharmacotherapy 2009;2:691-708.
23. Rostand SG, Drüeke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56: 383-392. (Pubitemid 29353135)
24. Wu J, Garami M, Cheng T, et al. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996;97:1577-1588. (Pubitemid 26105467)
25. Walker MD, Fleischer JB, Di Tullio MR, et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2010;95:2172-2179.
26. Atif F, Sayeed I, Ishrat T, et al. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med 2009;15:328-336.
27. Wilkins CH, Sheline YI, Roe CM, et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-1040. (Pubitemid 44936995)
28. Oudshoorn C, Mattace-Raso FU, van der Velde N, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25: 539-543. (Pubitemid 351957417)
29. Lee DM, Tajar A, Ulubaev A, et al; EMAS Study Group. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009;80:722-729.
30. Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010;170:1135-1141.
31. Schneiders J. Paper presented at European Society for Endocrinology meeting; Prague; April 25, 2010 [abstract 559].
32. Knekt P, Kilkkinen A, Rissanen H, et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010;67:808-811.
33. Evatt ML. Beyond vitamin status: Is there a role for vitamin D in Parkinson disease? Arch Neurol 2010;67:795-797.
34. Hoogendijk WJ, Lips P, Dik MG, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-512. (Pubitemid 351645046)
35. Hicks GE, Shardell M, Miller RR. Association between vitamin D status and pain in older adults: The Invecchiare in Chianti study. J Am Geriatr Soc 2008;56:785-791. (Pubitemid 351652383)
36. Kinney DK, Teixeira P, Hsu D, et al. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: A role for prenatal vitamin d deficiency and infections? Schizophr Bull 2009;35:582-595.
37. McGrath J, Saari K, Hakko H, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: A Finnish birth cohort study. Schizophr Res 2004;67:237-245. (Pubitemid 38251454)
38. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000;160: 1199-1203. (Pubitemid 30227032)
39. Roesel TR. Vitamin D deficiency in Iraq and Afghanistan veterans with chronic musculoskeletal pain. J Occup Environ Med 2008;50:613-614.
40. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003;78:1463-1470. (Pubitemid 37475629)
41. Block SR. Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin Proc 2004; 79:1585-1586; author reply 1586-1587.
42. Mascarenhas R, Mobarhan S. Hypovitaminosis DYinduced pain. Nutr Rev 2004;62:354-359.
43. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008;168:771-772. (Pubitemid 351563964)
44. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004;291:1999-2006. (Pubitemid 38544282)
45. Chaganti RK, Parimi N, Cawthon P, et al. Association of 25- hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: The osteoporotic fractures in men study. Arthritis Rheum 2010;62:511-514.
46. Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010;103:690-692.
47. AhmedW, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (G32 ng/mL) are associated with reversible myositis-myalgia in statintreated patients. Transl Res 2009;153:11-16.
48. Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiencyVa novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf ) 2009;71: 154-155.
49. Bittner V. Paper presented at the American College of Cardiology meeting; Atlanta, GA; March 15, 2010.
50. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-1956.
51. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.